Verastem Inc banner

Intrinsic Value

The intrinsic value of Verastem Inc (2VSA) under the Base Case is 12.441 EUR per share. Compared with the current market price of 5.596 EUR, the stock appears Undervalued by 55% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

2VSA Intrinsic Value
€12.441
Undervaluation 55%
Intrinsic Value
Price €5.596
Alert me when 2VSA is below its intrinsic value
Today €9.953 · Already reached, the price is 43.8% below it

2VSA is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to 2VSA

Fundamental Analysis

What Verastem Does

Biotechnology Health Care

Verastem is a biotechnology company focused on cancer drugs, especially medicines that target tumors driven by the RAS/MAPK signaling pathway. Its main work is to develop, test, and bring to market prescription therapies for hard-to-treat cancers, with a strong emphasis on ovarian cancer and other solid tumors. In simple terms, it is a drug maker, not a hospital or a research tools company.

Headquarters
United States of America US
Employees
102
IPO date
Nov 8, 2011
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 5, 2026

Verastem advanced VS-7375 toward frontline Phase III development, continued building its CO-PACK business, and outlined a CEO transition and a priority-review NDA.

Open the earnings call
EPS
−$0.74
Expected
−$0.44
Surprise
−68.2%
Stock, next trading day
−10.3%
View Earnings Call

Verastem insiders are selling within their usual range

Insider trading · Last trade on Nov 3, 2026

Sold $897.9k 4 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Past 12 months

Continue 2VSA Research

Decided on Verastem? Get an email when 2VSA reaches the price you’d buy at. Free with an account.

Other Verastem listings

What is the Intrinsic Value of one 2VSA stock?

The intrinsic value for Verastem Inc (2VSA) under the Base Case is 12.441 EUR.

Is 2VSA stock undervalued or overvalued?

Compared with the current market price of 5.596 EUR, the stock appears Undervalued by 55% .

How reliable are our estimates? See how past valuations played out
Back to Top